These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 35594163)

  • 1. Cancer Immunoediting in the Era of Immuno-oncology.
    Gubin MM; Vesely MD
    Clin Cancer Res; 2022 Sep; 28(18):3917-3928. PubMed ID: 35594163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer immunoediting and resistance to T cell-based immunotherapy.
    O'Donnell JS; Teng MWL; Smyth MJ
    Nat Rev Clin Oncol; 2019 Mar; 16(3):151-167. PubMed ID: 30523282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of Neoantigen-Mediated Immunoediting in Cancer Evolution.
    Wu T; Wang G; Wang X; Wang S; Zhao X; Wu C; Ning W; Tao Z; Chen F; Liu XS
    Cancer Res; 2022 Jun; 82(12):2226-2238. PubMed ID: 35486454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoediting Dynamics in Glioblastoma: Implications for Immunotherapy Approaches.
    Amin T; Hossain A; Jerin N; Mahmud I; Rahman MA; Rafiqul Islam SM; Islam SMBU
    Cancer Control; 2024; 31():10732748241290067. PubMed ID: 39353594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel strategies for cancer immunotherapy: counter-immunoediting therapy.
    Liu S; Sun Q; Ren X
    J Hematol Oncol; 2023 Apr; 16(1):38. PubMed ID: 37055849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Of Mice, Dogs, Pigs, and Men: Choosing the Appropriate Model for Immuno-Oncology Research.
    Overgaard NH; Fan TM; Schachtschneider KM; Principe DR; Schook LB; Jungersen G
    ILAR J; 2018 Dec; 59(3):247-262. PubMed ID: 30476148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy.
    Vesely MD; Schreiber RD
    Ann N Y Acad Sci; 2013 May; 1284(1):1-5. PubMed ID: 23651186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic applications of the cancer immunoediting hypothesis.
    Desai R; Coxon AT; Dunn GP
    Semin Cancer Biol; 2022 Jan; 78():63-77. PubMed ID: 33711414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Cancer Immunoediting to New Strategies in Cancer Immunotherapy: The Roles of Immune Cells and Mechanics in Oncology.
    Aragon-Sanabria V; Kim GB; Dong C
    Adv Exp Med Biol; 2018; 1092():113-138. PubMed ID: 30368751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunobiology of cancer immunosurveillance and immunoediting.
    Dunn GP; Old LJ; Schreiber RD
    Immunity; 2004 Aug; 21(2):137-48. PubMed ID: 15308095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational Quantification of Cancer Immunoediting.
    Liu K; He S; Sun S; Zhang X; He Y; Quan F; Pang B; Xiao Y
    Cancer Immunol Res; 2023 Sep; 11(9):1159-1167. PubMed ID: 37540180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-Dependent Immune Escape Due to Impaired Dendritic Cell Cross-Priming.
    Diamond MS; Lin JH; Vonderheide RH
    Cancer Immunol Res; 2021 Aug; 9(8):877-890. PubMed ID: 34145076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape.
    Mittal D; Gubin MM; Schreiber RD; Smyth MJ
    Curr Opin Immunol; 2014 Apr; 27():16-25. PubMed ID: 24531241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of resistance to T cell-based immunotherapy in head and neck cancer.
    Lee MY; Allen CT
    Head Neck; 2020 Sep; 42(9):2722-2733. PubMed ID: 32275098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances of RNA m
    Ma S; Barr T; Yu J
    Cancer Treat Res; 2023; 190():49-94. PubMed ID: 38112999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting.
    Matsushita H; Vesely MD; Koboldt DC; Rickert CG; Uppaluri R; Magrini VJ; Arthur CD; White JM; Chen YS; Shea LK; Hundal J; Wendl MC; Demeter R; Wylie T; Allison JP; Smyth MJ; Old LJ; Mardis ER; Schreiber RD
    Nature; 2012 Feb; 482(7385):400-4. PubMed ID: 22318521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OMIC signatures to understand cancer immunosurveillance and immunoediting: Melanoma and immune cells interplay in immunotherapy.
    León-Letelier RA; Bonifaz LC; Fuentes-Pananá EM
    J Leukoc Biol; 2019 May; 105(5):915-933. PubMed ID: 30698862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune approaches to the treatment of breast cancer, around the corner?
    Criscitiello C; Esposito A; Gelao L; Fumagalli L; Locatelli M; Minchella I; Adamoli L; Goldhirsch A; Curigliano G
    Breast Cancer Res; 2014 Feb; 16(1):204. PubMed ID: 25774617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and Gut Microbiota in Cancer Immunoediting, CD8/Treg Ratios, Immune Cell Homeostasis, and Cancer (Immuno)Therapy: Concise Review.
    Kareva I
    Stem Cells; 2019 Oct; 37(10):1273-1280. PubMed ID: 31260163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cancer Immunoediting in the Development of Cancer Immunotherapy].
    Ariyasu R; Nishikawa H
    Gan To Kagaku Ryoho; 2019 Mar; 46(3):407-411. PubMed ID: 30914573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.